Gil Bashe

Most recent articles by Gil Bashe

Wiesel’s wisdom a morality model for healthcare

Gil Bashe

September 21, 2018

10:33 am

For an industry hungry for ethical role models who transcend our fragmented healthcare system, a new book brings Elie Wiesel’s legacy into focus.

Elie Wiesel, Who Gave Voice to the Voiceless, Saw Pharma as an Ally in Sustaining Life

Gil Bashe

July 7, 2016

12:00 pm

He knew from his fractured childhood that courage in the face of adversity translated into survival and that empathy must be embedded in care and cures.

FTC ‘cure’ for reverse-payments worse than disease

Gil Bashe

September 15, 2010

6:49 pm

By now, you’ve probably heard about FTC efforts to ban reverse-payment patent settlements. FTC chairman Jon Leibowitz claims pharma-generic company deals are among “the most corrupt practices in healthcare today,” asserting settlements prevent cheaper generic drugs from entering the market sooner, delaying savings to consumers.

Social Etiquette

Gil Bashe

September 12, 2008

5:27 pm

Just as it followed other sectors into CRM, the pharma industry must find entry points into the online patient conversation. Gil Bashe explores some of the issues, hurdles and opportunities of Web 2.0

PR View by Gil Bashe

Gil Bashe

December 1, 2007

5:00 am

Treating rare disorders was once considered a “good-will science endeavor,” but market forces have encouraged companies to revisit how these small molecules can be big business, and researchers are finding that therapeutic applications for one rare disease area often holds promise in others.